![Mark Rothera](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Rothera
Director Ejecutivo en
VIRACTA THERAPEUTICS, INC.
.
Perfil
Mark A. Rothera is currently Chief Executive Officer at Viracta Therapeutics, Inc., Chief Executive Officer & Director at TreeFrog Therapeutics SAS starting in 2025, Director at Genpharm Services, and President & Director at Orchard Therapeutics North America.
Former roles include President, CEO & Executive Director at Silence Therapeutics Plc from 2020 to 2022; President, Chief Executive Officer & Director at Orchard Therapeutics (Europe) Ltd. from 2017 to 2020; President, CEO & Executive Director at Orchard Therapeutics Plc from 2018 to 2020; Director at Alliance for Regenerative Medicine; Director at INVO Fertility, Inc.; Chief Commercial Officer at PTC Therapeutics, Inc. from 2013 to 2017; Executive VP-Strategy & Business Development at Aegerion Pharmaceuticals, Inc. from 2012 to 2013; President & General Manager-Commercial Operations at Shire Human Genetic Therapies, Inc. from 2006 to 2012; and Vice President-Europe, Middle East & Africa at CHIRON Biopharmaceuticals from 2000 to 2005.
Education includes graduate studies at the University of Cambridge and an MBA from INSEAD.
Cargos activos de Mark Rothera
| Empresas | Cargo | Inicio |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Director Ejecutivo | - |
Genpharm Services
 Genpharm Services Advertising/Marketing ServicesCommercial Services Provides pharmaceutical marketing and consulting services | Director/Miembro de la Junta | - |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Presidente | - |
TreeFrog Therapeutics SAS
 TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Operates as a stem cell company | Director Ejecutivo | 15/12/2025 |
Antiguos cargos conocidos de Mark Rothera.
| Empresas | Cargo | Fin |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Director Ejecutivo | 21/02/2022 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Director Ejecutivo | 17/03/2020 |
| ORCHARD THERAPEUTICS PLC | Director Ejecutivo | 17/03/2020 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 09/08/2017 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2013 |
Formación de Mark Rothera.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
64
Relaciones de 1er grado
14
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 14 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
CHIRON Biopharmaceuticals | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Provides pharmaceutical marketing and consulting services | Commercial Services |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
TreeFrog Therapeutics SAS
TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Operates as a stem cell company | Commercial Services |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
- Bolsa de valores
- Insiders
- Mark Rothera
